-+ 0.00%
-+ 0.00%
-+ 0.00%

CORVUS PHARMACEUTICALS ANNOUNCES INITIAL DATA FROM SOQUELITINIB CLINICAL TRIAL IN PATIENTS WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) WILL BE PRESENTED AT THE 68ᵗʰ AMERICAN SOCIETY FOR HEMATOLOGY ANNUAL MEETING & EXPOSITION

Reuters·11/04/2026 14:01:00

Please log in to view news